The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins: A Novel Pathway for Inflammatory Cell Recruitment

Journal of Experimental Medicine

Volumn 198, Issue 10, 2003, Pages 1507-1515

  Chavakis, Triantafyllos ^a   Bierhaus, Angelika ^a   Al Fakhri, Nadia ^b   Schneider, Darius ^b   Witte, Steffen ^a   Linn, Thomas ^b   Nagashima, Mariko ^d   Morser, John ^d   Arnold, Bernd ^c   Preissner, Klaus T ^b   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d BAYER AG   (Germany)

Author keywords

Adhesion; Diabetes; Integrin; Leukocyte; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA2 INTEGRIN; CD11B ANTIGEN; DIMER; INTEGRIN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN S 100; THIOGLYCOLIC ACID;

ACUTE DISEASE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PURIFICATION; WILD TYPE;

ANIMALS; CHO CELLS; CRICETINAE; HUMANS; INFLAMMATION; INTEGRINS; LEUKOCYTES; MACROPHAGE-1 ANTIGEN; MICE; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC;

EID: 10744229528     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030800     Document Type: Article

References (35)

1. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell. 76:301-314.
2. Carlos, T.M., and J.M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood. 84:2068-2101.
3. Plow, E.F., T.A. Haas, L. Zhang, J. Loftus, and J.W. Smith. 2000. Ligand binding to integrins. J. Biol. Chem. 275:21785-21788.
4. Chavakis, T., K.T. Preissner, and S. Santoso. 2003. Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle. Thromb. Haemost. 89:13-17.
5. Schmidt, A.M., S.D. Yan, S.F. Yan, and D.M. Stern. 2001. The multiligand receptor RAGE as a progression gactor amplifying immune and inflammatory responses. J. Clin. Invest. 108:949-955.
6. Schmidt, A.M., S.D. Yan, J. Brett, R. Mora, R. Nowygrod, and D.M. Stern. 1993. Regulation of human mononuclear phagocyte migration by cell surface binding-proteins for advanced glycation end products. J. Clin. Invest. 91:2155-2168.
7. Li, J., and A.M. Schmidt. 1997. Characterization and functional analysis of the promoter of RAGE. J. Biol. Chem. 272:16498-16506.
8. Tanaka, N., H. Yonekura, S. Yamagishi, H. Fujimori, Y. Yamamoto, and H. Yamamoto. 2000. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275:25781-25790.
9. Yan, S.D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:685-691.
10. Hofmann, M., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides. Cell. 97:889-901.
11. Taguchi, A., D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, et al. 2000. Blockade of RAGE/amphoterin supresses tumor growth and metastases. Nature. 405:354-360.
12. Schmidt, A.M., M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, M. Clauss, et al. 1992. Isolation and characterization of binding proteins for advance glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267:14987-14997.
13. Kislinger, T., C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, M. Hoffmann, S.F. Yan, M. Pischetsrieder, D. Stern, and A.M. Schmidt. 1999. N(epsilon)-(carboxynaethyl)lysine adducts of proteins are ligands for RAGE that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274:31740-31749.
14. Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P.M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 50:2792-2808.
15. Bierhaus, A., T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P.P. Nawroth. 1997. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation. 96:2262-2271.
16. Wautier, J.L., C. Zoukourian, O. Chappey, M.P. Wautier, P.J. Guillausseau, R. Cao, O. Hori, D. Stern, and A.M. Schmidt. 1996. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble RAGE blocks hyperpermeability in diabetic rats. J. Clin. Invest. 97:238-243.
17. Schmidt, A.M., O. Hori, J.X. Chen, J.F. Li, J. Crandall, J. Zhang, R. Cao, S.D. Yan, J. Brett, and D. Stern. 1995. Advanced glycation endproducts interacting with their endothelial receptor induce expression of VCAM-1 in cultured human endothelial cells and in mice. J. Clin. Invest. 96:1395-1403.
18. Park, L., K.G. Raman, K.J. Lee, Y. Lu, L.J. Ferran, Jr., W.S. Chow, D. Stern, and A.M. Schmidt. 1998. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nat. Med. 4:1025-1031.
19. Goova, M., J. Li, T. Kislinger, W. Qu, Y. Lu, L.G. Bucciarelli, S. Nowygrod, B.M. Wolf, X. Caliste, S.F. Yan, et al. 2001. Blockade of RAGE restores effective wound healing in diabetic mice. Am. J. Pathol. 159:513-525.
20. Wendt, T.M., N. Tanji, J. Guo, T.R. Kislinger, W. Qu, Y. Lu, L.G. Bucciarelli, L.L. Rong, B. Moser, G.S. Markowitz, et al. 2003. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 162:1123-1137.
21. Renard, C., O. Chappey, M.P. Wautier, M. Nagashima, E. Lundh, J. Morser, L. Zhao, A.M. Schmidt, J.M. Scherrmann, and J.L. Wautier. 1997. Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats. Mol. Pharmacol. 52:54-62.
22. Chavakis, T., S.M. Kanse, R.A. Pixley, A.E. May, I. Isordia-Salas, R.W. Colman, and K.T. Preissner. 2001. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J. 15:2365-2376.
23. Chavakis, T., S.M. Kanse, F. Lupu, H.P. Hammes, W. Muller-Esterl, R.A. Pixley, R.W. Colman, and K.T. Preissner. 2000. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood. 96:514-522.
24. Chavakis, T., A.E. May, K.T. Preissner, and S.M. Kanse. 1999. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and β2-integrins. Blood. 93:2976-2983.
25. Lin, J.H., M. Wang, W.H. Andrews, R. Wydro, and J. Morser. 1994. Expression of efficiency of the human thrombomodulin-encoding gene in various vector and host systems. Gene. 147:287-292.
26. Santoso, S., U.J. Sachs, H. Kroll, M. Linder, A. Ruf, K.T. Preissner, and T. Chavakis. 2002. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counter-receptor for the leukocyte integrin Mac-1. J. Exp. Med. 196:679-691.
27. Chavakis, T., M. Hussain, S.M. Kanse, G. Peters, R.G. Bretzel, J.I. Flock, M. Herrmann, and K.T. Preissner. 2002. Staphylococcus aureus extracellular adherence protein (Eap) serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat. Med. 8:687-693.
28. Constien, R., A. Forde, B. Liliensiek, H.J. Grone, P. Nawroth, G. Hammerling, and B. Arnold. 2001. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis. 30:36-44.
29. Bucciarelli, L.G., T. Wendt, W. Qu, Y. Lu, E. Lalla, L.L. Rong, M.T. Goova, B. Moser, T. Kislinger, D.C. Lee, et al. 2002. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 106:2827-2835.
30. Ploplis, V.A., E.L. French, P. Carmeliet, D. Collen, and E.F. Plow. 1998. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood. 91:2005-2009.
31. Sligh, J.E., C.M. Ballantyne, S.S. Rich, H.K. Hawkins, C.W. Smith, A. Bradley, and A.L. Beaudet. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 90:8529-8533.
32. Newton, R.A., and N. Hogg. 1998. The human S100 protein MRP-14 is a novel activator of beta 2 integrin Mac-1 on neurrophils. J. Immunol. 160:1427-1435.
33. Schmidt, A.M., M. Hasu, D. Popov, J.H. Zhang, J. Chen, S.D. Yan, J. Brett, R. Cao, K. Kuwabara, G. Costache, et al. 1994. RAGE has a central role in vessel wall interactions and gene activation in response to AGEs. Proc. Natl. Acad. Sci. USA. 91:8807-8811.
34. Kislinger, T., N. Tanji, T. Wendt, W. Qu, Y. Lu, L.J. Ferran, Jr., A. Taguchi, K. Olson, L. Bucciarelli, M. Goova, et al. 2001. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 21:905-910.
35. Sakaguchi, T., S.F. Yan, S.D. Yan, D. Belov, L.L. Rong, M. Sousa, M. Andrassy, S.P. Marso, S. Duda, B. Arnold, et al. 2003. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Invest. 111:959-972.